Literature DB >> 11434510

Relationship between glutathione S-transferase M1, P1 and T1 polymorphisms and early onset prostate cancer.

Z Kote-Jarai1, D Easton, S M Edwards, S Jefferies, F Durocher, R A Jackson, R Singh, A Ardern-Jones, A Murkin, D P Dearnaley, R Shearer, R Kirby, R Houlston, R Eeles.   

Abstract

There is evidence suggesting that polymorphic variations in the glutathione S-transferases (GSTs) are associated with cancer susceptibility. Inter-individual differences in cancer susceptibility may be mediated in part through polymorphic variability in the bioactivation and detoxification of carcinogens. The GSTs have been consistently implicated as cancer susceptibility genes in this context. The GST supergene family includes several loci with well characterized polymorphisms. Approximately 50% of the Caucasian population are homozygous for deletions in GSTM1 and approximately 20% are homozygous for deletions in GSTT1, resulting in conjugation deficiency of mutagenic electrophiles to glutathione. The GSTP1 gene has a polymorphism at codon 105 resulting in an Ile to Val substitution which consequently alters the enzymatic activity of the protein and this has been suggested as a putative high-risk genotype in various cancers. We investigated the relationship between GST polymorphisms and young onset prostate cancer in a case-control study. GSTM1, GSTT1 and GSTP1 genotypes were determined for 275 prostate cancer patients and for 280 geographically matched control subjects. We found no significant difference in the frequency of GSTM1 or GSTT1 null genotypes between cases and controls. GSTP1 genotype was, however, significantly associated with prostate cancer risk: the Ile/Ile homozygotes had the lowest risk and there was a trend in increasing the risk with the number of 105 Val alleles: Ile/Val odds ratio (OR)= 1.30 (95% FCI 0.99-1.69), Val/Val OR = 1.80 (95% FCI 1.11-2.91); Ptrend = 0.026. These results suggest that the GSTP1 polymorphism may be a risk factor for developing young onset prostate cancer. We also found that carrying more than one putative high-risk allele in the carcinogen metabolizing GST family was associated with an elevated risk for early onset prostate cancer (OR 2.48, 95% FCI 1.22-5.04, Ptrend = 0.017).

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11434510     DOI: 10.1097/00008571-200106000-00007

Source DB:  PubMed          Journal:  Pharmacogenetics        ISSN: 0960-314X


  19 in total

Review 1.  Association between glutathione S-transferases M1 and T1 gene polymorphisms and prostate cancer risk: a systematic review and meta-analysis.

Authors:  Qiliang Cai; Zhun Wang; Wei Zhang; Xuemei Guo; Zhiqun Shang; Ning Jiang; Jing Tian; Yuanjie Niu
Journal:  Tumour Biol       Date:  2013-07-26

2.  Prostate cancer risk from occupational exposure to polycyclic aromatic hydrocarbons interacting with the GSTP1 Ile105Val polymorphism.

Authors:  Benjamin A Rybicki; Christine Neslund-Dudas; Nora L Nock; Lonni R Schultz; Ludmila Eklund; James Rosbolt; Cathryn H Bock; Kristin G Monaghan
Journal:  Cancer Detect Prev       Date:  2006-10-25

3.  Associations of oxidative balance-related exposures with incident, sporadic colorectal adenoma according to antioxidant enzyme genotypes.

Authors:  Julia Labadie; Michael Goodman; Bharat Thyagarajan; Myron Gross; Yan Sun; Veronika Fedirko; Roberd M Bostick
Journal:  Ann Epidemiol       Date:  2013-01-03       Impact factor: 3.797

4.  Association of GSTM1T1 genes with COPD and prostate cancer in north Indian population.

Authors:  Hitender Thakur; Lipsy Gupta; Ranbir C Sobti; Ashok K Janmeja; Amlesh Seth; Sharwan K Singh
Journal:  Mol Biol Rep       Date:  2010-09-15       Impact factor: 2.316

5.  Relationship among metabolizing genes, smoking and alcohol used as modifier factors on prostate cancer risk: exploring some gene-gene and gene-environment interactions.

Authors:  Dante D Cáceres; Jeannette Iturrieta; Cristian Acevedo; Christian Huidobro; Nelson Varela; Luis Quiñones
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

6.  Association of GSTT1 gene polymorphisms with the risk of prostate cancer: an updating meta-analysis.

Authors:  Jihong Wang; Yuemin Xu; Qiang Fu; Jianjun Yu; Zhong Chen; Zhangshun Liu; Chao Li; Hui Guo; Mingkai Xie
Journal:  Tumour Biol       Date:  2013-03-02

Review 7.  Association between the GSTP1 Ile105Val polymorphism and prostate cancer risk: a systematic review and meta-analysis.

Authors:  Zhuo Yu; Zhong Li; Bing Cai; Ziming Wang; Weimin Gan; Haiwen Chen; Hecheng Li; Peng Zhang; Hongliang Li
Journal:  Tumour Biol       Date:  2013-03-14

Review 8.  Genetic polymorphisms in glutathione S-transferases P1 (GSTP1) Ile105Val and prostate cancer risk: a systematic review and meta-analysis.

Authors:  Qiliang Cai; Tao Wu; Wei Zhang; Xuemei Guo; Zhiqun Shang; Ning Jiang; Jing Tian; Yuanjie Niu
Journal:  Tumour Biol       Date:  2013-07-11

9.  Associations between smoking, polymorphisms in polycyclic aromatic hydrocarbon (PAH) metabolism and conjugation genes and PAH-DNA adducts in prostate tumors differ by race.

Authors:  Nora L Nock; Deliang Tang; Andrew Rundle; Christine Neslund-Dudas; Adnan T Savera; Cathryn H Bock; Kristin G Monaghan; Allison Koprowski; Nicoleta Mitrache; James J Yang; Benjamin A Rybicki
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-06       Impact factor: 4.254

10.  Significant association of Glutathione S-transferase T1 null genotype with prostate cancer risk: a meta-analysis of 26,393 subjects.

Authors:  Qing Yang; Jun Du; Xin Yao
Journal:  PLoS One       Date:  2013-01-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.